financetom
Business
financetom
/
Business
/
Update: Surgery Partners Shares Fall After Q3 Results, Lowered Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Surgery Partners Shares Fall After Q3 Results, Lowered Guidance
Nov 10, 2025 10:09 AM

12:58 PM EST, 11/10/2025 (MT Newswires) -- (Updates with the company's latest stock move in the headline and the first paragraph.)

Surgery Partners ( SGRY ) shares were down 24% in recent Monday trading after the company reported Q3 results and lowered its 2025 revenue guidance.

The company reported Q3 adjusted net income Monday of $0.13 per diluted share, down from $0.19 a year earlier.

Two analysts polled by FactSet expected $0.20.

Revenue for the quarter ended Sept. 30 was $821.5 million, up from $770.4 million a year earlier.

Analysts surveyed by FactSet expected $820.0 million.

For 2025, the company lowered its revenue projection to $3.28 billion to $3.30 billion, down from its previous guidance of $3.30 billion to $3.45 billion.

Analysts polled by FactSet expect $3.35 billion.

Price: 16.29, Change: -5.21, Percent Change: -24.23

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
QuidelOrtho Reports Preliminary Q4 Revenue in Line With Guidance
QuidelOrtho Reports Preliminary Q4 Revenue in Line With Guidance
Jan 13, 2025
01:39 PM EST, 01/13/2025 (MT Newswires) -- QuidelOrtho ( QDEL ) said Monday it expects Q4 revenue of $702 million to $707 million, in line with guidance. Analysts polled by FactSet project $698.1 million. The company plans to release Q4 and 2024 results on Feb. 12. Price: 45.27, Change: -0.48, Percent Change: -1.05 ...
Lilly asks US government to pause drug price negotiations, Bloomberg News reports
Lilly asks US government to pause drug price negotiations, Bloomberg News reports
Jan 13, 2025
(Reuters) -Eli Lilly ( LLY ) has asked the U.S. government to pause price negotiations for prescription drugs, Bloomberg News reported on Monday, citing CEO David Ricks. Ricks said at the JPMorgan Healthcare Conference that the government needs to fix the Inflation Reduction Act (IRA) before the second round of talks over price cuts, the report added. The outgoing administration...
Market Chatter: Edison International Utility Hit With Lawsuit Over Wildfire in Los Angeles
Market Chatter: Edison International Utility Hit With Lawsuit Over Wildfire in Los Angeles
Jan 13, 2025
01:42 PM EST, 01/13/2025 (MT Newswires) -- Edison International's ( EIX ) southern California utility is facing a lawsuit blaming the company's equipment for igniting a wildfire in Los Angeles, Bloomberg reported Monday. The legal complaint filed in Los Angeles Superior Court blames the fire in the Altadena community to a Southern California Edison power distribution line pole. The court...
What's Going On With 22nd Century Group Shares Monday?
What's Going On With 22nd Century Group Shares Monday?
Jan 13, 2025
22nd Century Group, Inc. ( XXII ) stock is moving higher on Monday after the company announced its readiness to support the Food and Drug Administration’s (FDA) proposed standard to mandate reduced nicotine content in cigarettes. What To Know: The proposed standard aligns with the FDA’s long-standing effort to drastically reduce nicotine levels in cigarettes and is consistent with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved